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Background: 22q11.2 deletion syndrome (22q11DS) is associated with a number of physical anomalies and
neuropsychological deficits including impairments in executive and sensorimotor function. It is estimated that 25%
of children with 22q11DS will develop schizophrenia and other psychotic disorders later in life. Evidence of genetic
transmission of information processing deficits in schizophrenia suggests performance in 22q11DS individuals will
enhance understanding of the neurobiological and genetic substrates associated with information processing. In
this report, we examine information processing in 22q11DS using measures of startle eyeblink modification and
antisaccade inhibition to explore similarities with schizophrenia and associations with neurocognitive performance.
Methods: Startle modification (passive and active tasks; 120- and 480-ms pre-pulse intervals) and antisaccade inhibition
were measured in 25 individuals with genetically confirmed 22q11DS and 30 healthy control subjects.
Results: Individuals with 22q11DS exhibited increased antisaccade error as well as some evidence (trend-level effect) of
impaired sensorimotor gating during the active condition, suggesting a dysfunction in controlled attentional
processing, rather than a pre-attentive dysfunction using this paradigm.
Conclusions: The findings from the present study show similarities with previous studies in clinical populations
associated with 22q11DS such as schizophrenia that may indicate shared dysfunction of inhibition pathways in these
groups.
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22q11.2 deletion syndrome (22q11DS) is caused by a dele-
tion on the long arm of chromosome 22 and is thought to
affect between 30 and 60 genes associated with brain devel-
opment and function [1]. Our ability to function and thrive
in life is reliant on our capacity to select and attend to
salient information in our environment and to ignore or
inhibit non-salient information. The impairment of inhibi-
tory information processes is associated with a wide range* Correspondence: Linda.E.Campbell@newcastle.edu.au
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unless otherwise stated.of psychiatric illnesses [2], including those common to
22q11DS such as schizophrenia. People with 22q11DS are
at a greater risk of developing schizophrenia and other
psychotic disorders [3-5], and genome-wide association
studies (GWAS) indicate that the 22q11.2 deletion repre-
sents the strongest known genetic association in schizo-
phrenia [1,6]. Compared to control participants, people
with schizophrenia as well as their first-degree relatives
show poorer performance on inhibitory information
processing measures of pre-pulse inhibition [PPI; [7-10]]
and antisaccade inhibition [11,12]. There is also evidence
to suggest that pre-pulse inhibition is similarly impaired in
22q11DS [13,14]. Inhibitory dysfunction observed prior to
the onset of schizophrenia in groups at a genetic high riskl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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represent a trait marker for developing schizophrenia [10].
Moreover, information processing difficulties may also
account for some of the higher-order cognitive impair-
ments that are commonly reported in 22q11DS such as
executive dysfunction [15].
PPI is a measure of reduction of the acoustic startle
response when a weak non-startling stimulus (pre-pulse;
S2) is presented before a startling stimulus (S1) [16] and
reflects pre-attentive and automatic sensorimotor gating
mechanisms [17]. Reduced PPI has been consistently
reported in people with schizophrenia [7,9,18], and it is
considered a potential endophenotype for the disorder [9].
In healthy controls, typical levels of PPI are between 50%
and 60% (though levels are influenced by factors such as
stimulus type (e.g. white noise/pure tone) and interstimu-
lus interval (ISI)) [18]. However, when variations of this
paradigm include both attended and unattended condi-
tions, individuals with schizophrenia show deficits in PPI
only when instructed to attend to the pre-pulse [19,20].
While reduced PPI is reported using unattended measures
of PPI alone, it is not known whether impaired attention
modulation of PPI is similarly observed in 22q11DS as in
schizophrenia.
The antisaccade paradigm is another measure of inhibi-
tory information processing and requires the participant
to suppress a saccade to a stimulus (prosaccade) and
generate a saccade to the mirror position (antisaccade)
[21]. It is a voluntary executive control process regulated
strongly by prefrontal cortical areas; however, both early
pre-attentional or automatic and later controlled atten-
tional processes contribute to generating the antisaccade
[22]. In healthy controls, antisaccade error rate is esti-
mated at 20% [23], and in schizophrenia, antisaccade error
rate is significantly and consistently higher and is associ-
ated with poor executive functioning [24-26]. Despite
evidence of poor executive functioning in 22q11DS
[15,27] and evidence linking antisaccade impairment to a
locus on chromosome 22q11-12 [28], antisaccade per-
formance has not been examined in 22q11DS.
The present study sought to extend previous inhibi-
tory information processing studies in 22q11DS by
examining attended and unattended measures of PPI,
antisaccade inhibition and associations with executive
functioning prior to the onset of overt psychosis. Con-
sistent with previous studies [14], we expect to report
reduced unattended PPI in participants with 22q11DS.
Given evidence of attention deficits in 22q11DS, it is
expected that when instructed to attend to the pre-pulse,
compared to typically developing control participants, the
22q11DS group will fail to show normal attentional
modulation of the startle response. In addition, we expect
to show increased antisaccade error rates in the 22q11DS
group compared to typically developing controls and thatpoorer antisaccade performance will be associated with
poorer performance on attention-dependent neuropsycho-
logical tasks (executive functioning) in both groups.
Methods
The study protocol was approved by the University of
Newcastle Australia Human Research Ethics Committee.
Informed consent was obtained from all participants
who took part in the study in accordance with the Code
of Ethics of the World Medical Association (Declaration
of Helsinki).
Participants
We present the data from 25 adolescents (mean age
16.8 ± 2.9 years, 10 male subjects) with genetically
confirmed 22q11DS recruited from the VCFS & 22q11
Foundation, Australia, and from local health services.
The control subjects (HC) were 30 siblings of 22q11DS
participants or other typically developing adolescents re-
cruited from the community (mean age 16.5 ± 3.5 years,
14 male subjects). Exclusion criteria for the 22q11DS
participants were the presence of the clinical phenotype
of 22q11DS without a confirmed 22q11.2 deletion, a
clinically detectable medical disorder known to affect
brain structure (e.g. epilepsy or hypertension) or a
history of head injury. Exclusion criteria for the HC
sample were the presence of a genetic disorder or a
major mental health problem. Additional exclusion
criteria for both groups included a history of severe head
injury, seizure disorder or other ocular, neurological or
medical problems that could influence task performance.
Visual acuity and auditory thresholds were assessed in all
subjects prior to testing using a Snellen chart and
audiometric assessment of hearing (range: 250 Hz–6 kHz).
A psychiatrist (author: US) conducted a structured diag-
nostic interview [K-SADS; [29]] at the time of testing to
determine 22q11DS participants’ diagnostic status. Eleven
individuals with 22q11DS were identified as having (or
having had) psychiatric diagnoses such as ADHD (n = 3),
oppositional defiant disorder (n = 2), generalized anxiety
disorder (n = 2), obsessive-compulsive disorder (n = 3),
trichotillomania (n = 1) and major depressive disorder
(n = 1). Six individuals were currently on medication;
antipsychotics: risperidone (n = 2), mood stabilizers:
valproate (n = 2), methylphenidate (n = 4) or SSRIs (n = 4).
One participant was diagnosed with schizophrenia at the
time of interview. The data of this participant was
excluded because of non-compliance with task instruc-
tions for antisaccade and PPI.a
IQ and executive functioning
Intellectual functioning
The Wechsler Abbreviated Scale of Intelligence [WASI
4 subscale version; [30]] was used to assess general
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full-scale IQ calculated.
Planning task
A computerised planning task based on the Tower of
London (ToL) task was designed. A goal and start con-
figuration was shown simultaneously in the upper and
lower half of the screen. The goal configuration was
smaller in size and surrounded by a distinct square. An
image of three pegs of decreasing heights and three balls
of different colours were displayed. The task was dis-
played on a touch screen. Only one ball could be moved
at a time. A ball could only be moved if there was no
other ball on top, and three balls could be placed on the
long peg, two on the medium and one on the shortest
peg. The participants were instructed to transform the
start state into the goal state by touching the appropriate
ball (to activate it) and then touch the end-position to
move the ball. The planning task ranged from 2–7
moves necessary for completion. There was no time
limit to solve a problem. Variables recorded were moves
above minimum, initial thinking time and subsequent
thinking time. All participants received feedback at the
end of each trial, consisting of a smiley face in different
colours (yellow for perfect performance and purple for
passing the trial) or a sad face when failing the trial. All
participants also completed a motor control task, in
order to control for motor movement time. This con-
sisted of a five-move task that was broken down into 5
one-move tasks so that there should be no thinking
time, and all time should be taken up by movement.
This time was subtracted from the movement execution
time. The participants completed the practice trials
before commencing the task and followed by a two-
move condition to understand the goal of the main task.
These trials were not included in the data analysis.
Experimental tasks
PPI measures
Electromyographic (EMG) recordings of sensorimotor
gating of the acoustic startle eyeblink response were
undertaken. Auditory stimuli were generated using a
presentation software (Neurobehavioural Systems) and
were presented binaurally through stereo headphones
using a set-up similar to earlier published studies [31].
The startle stimuli were rectangular white noise (50-ms
duration, 110 dB sound pressure level (SPL)). Pre-pulse
stimuli consisted of two pure tones (high-pitch 1,400 Hz,
20 ms, 5-ms ramp or a low-pitch 800 Hz, 20 ms, 5-ms
ramp) at 80 dB SPL (against ~70 dB SPL background
noise) presented either 120 or 480 ms before startle
stimulus onset. All acoustic stimuli were calibrated using
a Bruel and Kaejer sound level meter (type 2231) and
artificial ear (type 4151). There were three trial types: (i)startle baseline (startle probe only); (ii) 120-ms pre-pulse
and (iii) 480-ms pre-pulse. There were several practice
trials for each of the attended and unattended conditions
and a total of ten instances in each condition (120 ms
passive/active; 480 ms passive/active). The stimulus
sequence commenced with the presentation of three
startle baseline trials that were discarded and excluded
from the analyses. This was followed by an alternating
sequence of 20 startle baseline and 20 pre-pulse trials
with a variable interstimulus interval of 10–12 s. Within
this sequence, 120-ms and 480-ms pre-pulse trials were
presented equally in a pseudorandomised order. Two
conditions were presented, a passive and an active with
the passive condition completed first by all participants.
In the passive condition, participants were instructed to
ignore the stimuli and make no overt response while
watching a silent movie. For the active condition, partici-
pants were instructed to listen to the stimuli and were
required to respond to the high-pitch tone by pressing a
button as quickly and accurately as possible.
EMG recording and analyses
Bipolar silver/silver chloride electrodes were positioned
above the orbicularis oculus muscle of the subject’s left eye
to record the blink response (A/D rate of 1,000 Hz and
amplified × 500). Impedances were reduced to less than 5 k
Ω. EMG activity was band-pass filtered (1–200 Hz with
50 Hz notch). Epochs were extracted from 50-ms pre-
startle to 300-ms post-startle stimulus onset, baseline cor-
rected over the 50-ms pre-stimulus interval, rectified and
averaged separately for each of the three trial types. Startle
response amplitude was determined as the integral aver-
aged under the curve occurring between 30 and 150 ms
from the onset of startle stimulus. Eight 22q11DS partici-
pants did not complete the EMG session. Seventeen indi-
viduals with 22q11DS undertook PPI recordings (mean age
16.7 ± 2.8 years, 5 male subjects) and 19 HC (mean age
16.3 ± 4.0 years, 8 male subjects).
Antisaccade recording and analysis
Participants’ eye movements were recorded remotely using
an Eyelink 1000 (1,000 Hz, SR Research, Ontario, Canada)
linked to a host Dell Pentium IV PC processor and an
auxiliary video display unit for observing the monitored
eye. Each stimulus block was preceded by a calibration and
validation procedure that required participants to fixate on
a 3 × 3 matrix of centrally and peripherally located points
on the computer screen. Each trial consisted of the follow-
ing sequence: (i) a circular target was presented at the
beginning of each trial; (ii) after 1,000 ms, the target was
extinguished, a peripheral target was illuminated and a
brief beeping signal was initiated and (iii) an extinction of
the cue occurred after 3,000 ms or earlier if participant
gaze was recorded within 1° (visual angle) of the target
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greater than 1,000 ms. The target stimulus, a small red
target of 0.9° in diameter, was presented on a black
computer screen. The stimuli in each block were pre-
sented to the left or right of the screen in a balanced
pseudorandom order. An antisaccade error occurred
when the subject made a reflexive saccade towards the tar-
get before correctly making a saccade in the opposite
direction. Antisaccade errors were identified using custom
software and expressed as a percentage of the total. Seven-
teen individuals with 22q11DS undertook antisaccade
recordings (mean age 17.1 ± 3.08 years, 7 male subjects)
and 28 HC (mean age 16.7 ± 3.4, 13 male subjects).
Analysis
SPSS 19 was employed for statistical analyses. In both
participant groups, with the exception of antisaccade error
and latency, the distribution of inhibition measures did not
violate assumptions of normality (Shapiro–Wilks test) and
parametric statistics were used in subsequent analyses.
PPI was determined as a percentage and calculated for
each ISI in each stimulus condition using the formula:
Percent PPI = 100 × [(startle pulse only units − pre-pulse-
startle pulse response units)/startle pulse only units]. PPI
measures were examined using repeated measures t-tests
and mixed model ANOVA (pre-pulse interval [120 ms,
480 ms] × attention [passive, active] × group). Antisac-
cade accuracy, amplitude and latency (of correct and in-
correct trials separately) were calculated using software
designed for eye movement analysis, and antisaccade
accuracy data were examined using one-way ANOVAs.
Independent samples t-tests, chi square and one-way
ANOVA were used to examine demographic and execu-
tive functioning differences between groups. Parametric
correlational analyses were conducted to examine rela-
tionships between executive functions and performance
measures on antisaccade and PPI. Threshold set for
significance was 0.05.
Results
A total of 55 adolescents were included in these analyses;
however, not all participants completed both antisaccade
and PPI components of the study. As such, sample size var-
ied depending on the analysis. The groups (22q11DS/HC)
did not differ from each other in age (t(53) = 0.28, p =
0.78) or gender (χ2(1) = 0.25, p = 0.62), but IQ differ-
ence was greater than two standard deviations between
groups (Full-scale IQ: mean (SD): 22q11DS = 75.4
(15.3); HC = 104.4(15.8), Table 1).
Pre-pulse inhibition (PPI) task performance
Startle eyeblink responses were modulated by pre-pulse
interval (120/480 ms: F(1,34) = 9.84, p = 0.004) and by
condition (passive/active: F(1,34) = 35.98, p < 0.001). Bothgroups showed PPI to the 120-ms pre-pulse interval ver-
sus baseline startle response (no pre-pulse presented) in
both the passive and active pre-pulse conditions (passive
task: t(18) = 2.72, p = 0.014 HC subjects; t(16) = 5.35, p <
0.001 22q11DS subjects; active task: t(18) = 4.30, p < 0.001
HC subjects; t(16) = 2.58, p = 0.02 22q11DS subjects,
Table 2).
The three-way interaction of pre-pulse interval by
attention conditions by group approached significance
(F(1,34) = 3.83, p = 0.059; Figure 1). Post hoc testing
revealed a differential modulation of sensorimotor gat-
ing between groups. HC participants showed a signifi-
cant increase in PPI in the 120-ms pre-pulse interval
when directing attention to the pre-pulse, compared to
the passive listening task (t(18) = −2.42, p = 0.026). In
contrast, 22q11DS subjects showed a trend towards
reduced PPI when directing attention to the pre-pulse
(t(16) = −1.80, p = 0.09) at the 120-ms pre-pulse interval
compared to the passive listening task. Moreover,
22q11DS subjects showed significantly greater PPF in the
passive listening task at the 480-ms pre-pulse interval com-
pared to the active listening task (t(16) = −2.31, p = 0.035).
Figure 1 indicates both groups exhibit PPF; however, this
differs between conditions, with the HC group exhibiting
greater (although statistically non-significant) PPF during
the active condition.
The ANOVA revealed no additional significant inter-
actions with none of the following conditions reaching
significance: interval by group (F(1,34) = 0.045, p >
0.05); condition by group (F(1,34) = 0.08, p > 0.05) nor
interval by condition (F(1,34) = 0.00, p > 0.05).
Antisaccade task performance
Group comparisons on antisaccade error, latency and
amplitude showed the 22q11DS group made signifi-
cantly more antisaccade errors compared to the HC
group (F(1,43) = 28.93, p < 0.0001) but did not differ on
measures of latency or amplitude (p > 0.05). These
effects remained non-significant when separated by trial
accuracy (correct/incorrect antisaccade). However, anti-
saccade error was influenced by response latency with
increased latency for successful antisaccade inhibition
trials in both groups (F(1,41) = 41.63, p < 0.0001)
(Table 3).
Associations amongst antisaccade, PPI and executive
functioning
Statistical significance of the difference between correlation
coefficients for the 22q11DS and HC groups was examined
because the patterns of association differed between the
groups on several measures. Where the groups did not
differ significantly (z(obs): −1.96–1.96), we performed partial
correlations controlling for group membership to explore
the relationship between the key variables of interest.
Table 1 Neuropsychological characteristics of the 22q11DS and HC groups
Cognitive data 22q11DS (n = 23) HC group (n = 27) Statistic t
(df)Mean SD Mean SD
IQ
Verbal IQ score 76.9 13.1 104.6 17.2
Performance IQ score 72.9 14.0 108.0 14.7
Full-scale IQ score 75.2 15.0 107.2 15.6
Executive functioningPlanning: Tower of London
Moves above minimum 3.11 3.02 0.97 0.56 14.71 (1,48)**
Initial thinking time (ms) (3–5 moves) 5,572 1,992 11,148 7,670 11.46 (1,48)**
Subsequent thinking time (ms) (3–5 moves) 25,202 3,253 12,172 6,427 4.16 (1,48)*
*p < 0.05; **p < 0.001.
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lated to account for the increased possibility of type-I error.
Following Bonferroni correction, antisaccade error was
moderately associated with executive function measures of
planning ability, with increased moves on the Tower of
London task associated with increased rates of antisaccade
error (df = 37, r = 0.447, p = 0.004). Zero-order correlations
indicated a moderate effect of group (r = 0.630).
Discussion
This study set out to characterise inhibitory information
processing in 22q11DS, using multiple measures (active/
passive SEM (PPI and PPF); antisaccade inhibition) and
examine potential associations with executive functioning.
This is the first study to systematically examine automatic
and controlled components of information processing and
their relationship to executive functioning in 22q11DS.
We report evidence of impaired controlled attentional
processes, i.e. antisaccade inhibition in 22q11DS individ-
uals, as well as some evidence (though statistically non-
significant) of sensorimotor gating deficits—in a prepulse
inhibition paradigm with reduced attentional modulation
of the startle eyeblink response.Table 2 Electromyographically recorded startle eyeblink resp
presentations of subtle acoustic pre-pulses at 120- and 480-m
22q11DS (n = 17)
%P
Passive listening task
Baseline startle 111.98 (±73.07) μV
120-ms pre-pulse 87.08 (±65.25) μV 22.8
480-ms pre-pulse 136.08 (±81.6) μV −24
Active discrimination task
Baseline startle 94.9 (±69.1) μV
120-ms pre-pulse 73.7 (±61.0) μV 15.5
480-ms pre-pulse 99.0 (±84.7) μV −12
Resulting percent change as pre-pulse inhibition (%PPI) or pre-pulse facilitation (%PPrevious studies of PPI in 22q11DS have found impaired
sensorimotor gating compared to typically developing
controls when employing a passive PPI task [14]; however,
group differences on the passive PPI component of the
task were not reported in the present study. Differing
methodologies including lead intervals, levels of white
background noise, relative stimulus intensities and
number of trials presented may account for this disparity
[18,32]. Additionally, the effects of age on PPI may explain
the difference in results, with a younger sample recruited
by Sobin and colleagues [14]. Others have recently
reported that levels of PPI increase with age [33], indicat-
ing that the age of our cohort may have contributed to the
differences between this study and previous reports of PPI
in 22q11DS [18,17]. We are currently limited to specula-
tion regarding the maturational trajectory of PPI in
clinical groups; however, based on the current findings,
differences in a PPI paradigm may best explain the low
levels of PPI reported for both 22q11DS and HC groups in
this study compared to previous reports in both 22q11DS
[14] and other populations which typically report PPI in
healthy control participants around 50%–60% [18]. These
floor effects in our passive PPI condition may explain ouronses at baseline (no pre-pulse presented) and following
s lead intervals
HC group (n = 19)
PI or %PPF %PPI or %PPF
133.2 (±117.3) μV
(±5.6) 109.3 (±103.8) μV 17.1 (±8.3)
.4 (±11.7) 131.2 (±100.8) μV −3.1 (±8.5)
104.9 (±72.6) μV
(±11.9) 68.6 (±53.1) μV 34.1 (±5.4)
.8 (±18.3) 114.2 (±86.2) μV −23.3 (14.0)
PF) relative to baseline startle response (standard error mean in parenthesis).
Figure 1Mean percent pre-pulse inhibition or pre-pulse facilitation
for 120- and 480-ms pre-pulse lead intervals. Mean percent
pre-pulse inhibition (PPI) or pre-pulse facilitation (PPF) for 120- and
480-ms pre-pulse lead intervals relative to baseline startle response (no
pre-pulse presented). Note differential attention effects on PPI and PPF
between groups depending on performance on an auditory
discrimination task on the pre-pulse (active) and not (passive).
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executive functioning and PPI that have been reported
previously in 22q11DS [13] and clinical conditions preva-
lent in 22q11DS [autism spectrum disorder; ASD [34]].
The results of the present study indicate attention-
modulated disruption of sensorimotor gating in 22q11DS.
One of the purposes of this study was to investigate
higher- and lower-order levels of information processing
in 22q11DS. Therefore, we incorporated a PPI paradigm
that systematically examined relatively automatic (passive
task) and controlled (active task) attention. During active
attendance, the effects of an acoustic pre-pulse are typically
magnified, with an increase in startle suppression (i.e. in-
crease in PPI) at short lead intervals and increased startle
(i.e. decrease PPI or increase PPF) at longer lead intervals
[17]. We showed that individuals with 22q11DS appear to
exhibit appropriate inhibition and facilitation of the startle
response during the passive task, indicating normal early
or automatic information processing. However, by failing
to display the normal pattern of greater PPI and PPF dur-
ing attended, rather than ignored, pre-pulses, the 22q11DS
group exhibited a dysfunction in controlled attentional
processing, rather than a pre-attentive dysfunction.Antisaccade inhibition
This is the first time antisaccade inhibition has been
examined in 22q11DS. Our results were consistent withTable 3 Mean (SD) antisaccade parameters for 22q11DS and
22q11DS mean (
Mean% error 51.3 (19.57)
Mean latency (ms) 257.99 (92.68)
Mean latency (ms) (correct) 300.45 (155.9)
Mean latency(ms) (incorrect) 221.49 (66.60)
Mean amplitude (o/s) 1.44 (0.12)
***p < 0.0001.reports from other clinical populations [schizophrenia [25],
first episode psychosis [35]] indicating that 22q11DS
participants were less able to inhibit an automatic pre-
potent response (i.e. increased antisaccade error). Increased
antisaccade error in 22q11DS may reflect the inhibitory
demands of the task and support our PPI findings of
impaired controlled attention processes in 22q11DS.
Our findings are also consistent with studies that show
poor antisaccade performance in ultra-high risk for
schizophrenia [36] and first episode schizophrenia
groups [37].
Our passive PPI task was uncorrelated with the antisac-
cade task. This is consistent with previous studies in
schizophrenia that show no association between passive
PPI and antisaccade accuracy [38]. We partly concur with
Swerdlow et al. [39] that the absence of association be-
tween passive PPI and antisaccade indicates that the mea-
sures are partly “dissociable and non-redundant” (p336)
measures of information processing, resembling tasks
tapping early versus late portions of the information pro-
cessing chain. The present study shows poorer antisaccade
accuracy, as well as attention-modulation deficits in PPI in
22q11DS. Taken together, these findings suggest a more
cortical, in particular prefrontal, than subcortical (i.e.
superior collicular) dysfunction in our 22q11DS sample.Limitations
Several limitations are associated with this study. The
lack of an intellectually matched control group and
convenience recruitment approach to participant selec-
tion is inherent to research of this nature and a limita-
tion in 22q11DS research noted by our group
previously [40]. In addition, 22q11DS is associated with
a range of mental health conditions (see Participants);
and these diagnoses and the medications used to treat
them may have influenced our findings. However, these
clinical diagnoses also reflect a defining characteristic
of 22q11DS and were too few in number and varied in
type to control statistically. Regarding medication, it is
unclear how best to control for the influence of
medication status given the medication participants
reported using at the time of testing may have im-
proved or impaired performance on inhibition tasks. InHC groups
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additional controls for medication and clinical status in
a larger sample.
Clinical implications
The path of cognitive maturation in 22q11DS remains
unclear; and future studies may benefit from the inclusion
of participants aged across the lifespan to help determine
whether inhibition processes are underdeveloped, delayed
or constant across the lifespan in this group. Future
studies may also benefit from exploring the influences of
GABA, dopamine and glutamate transmission [13], as
they are likely to be involved in the disturbed attention-
modulated PPI and, we would suggest, the poor antisac-
cade performance reported in the current sample.
Conclusions
The present study undertook a comprehensive examin-
ation of inhibitory functioning in 22q11DS using multiple
measures and examined their relationship to executive
functioning. While impaired PPI was not reported using
the current paradigm, we identified similarities with find-
ings reported in clinical populations associated with
22q11DS such as schizophrenia that may indicate shared
dysfunction of inhibition pathways in these groups.
Endnote
aThe pattern of associations reported for the antisac-
cade task did not differ when this participant was in-
cluded in analysis and we did not have PPI data for this
participant.
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